(Q46317510)

21 December 2017

title

Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer (English)

1 reference

21 December 2017

Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

1 reference

1 reference

1

1 reference

21 December 2017

Luca Guerra

8

1 reference

21 December 2017

Cinzia Crivellaro

object named as

Cinzia Crivellaro

5

0 references

author name string

Federica Sina

2

1 reference

21 December 2017

Carlotta Dolci

3

1 reference

21 December 2017

Mauro Signorelli

4

1 reference

21 December 2017

Tiziana Dell'Anna

6

1 reference

21 December 2017

Marco Cuzzocrea

7

1 reference

21 December 2017

Rodolfo Milani

9

1 reference

21 December 2017

Cristina Messa

10

1 reference

21 December 2017

language of work or name

English

0 references

publication date

27 September 2013

1 reference

21 December 2017

published in

Gynecologic Oncology

1 reference

21 December 2017

volume

131

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

689-693

1 reference

21 December 2017

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Preoperative staging of cervical cancer: Is 18-FDG-PET/CT really effective in patients with early stage disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Stage IV ovarian cancer: impact of surgical debulking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Effect of surgical debulking on survival in stage IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

7 January 2021

Carcinoma of the Ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Natural history of stage IV epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Mediastinal lymphatic efferents from the diaphragm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Analysis of gene expression in early-stage ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

ΔNp63 expression is associated with poor survival in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

Decoding global gene expression programs in liver cancer by noninvasive imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

VEGF-A and its isoform VEGF121 mRNA expression measured by quantitative real-time RT-PCR: correlation with F-18 FDG uptake and aggressiveness of lung adenocarcinoma: preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.09.024

10.1016/J.YGYNO.2013.09.024

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017